1. Home
  2. EZRA vs AEMD Comparison

EZRA vs AEMD Comparison

Compare EZRA & AEMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Reliance Global Group Inc. Common Stock

EZRA

Reliance Global Group Inc. Common Stock

N/A

Current Price

$2.80

Market Cap

2.1M

Sector

Finance

ML Signal

N/A

Logo Aethlon Medical Inc.

AEMD

Aethlon Medical Inc.

HOLD

Current Price

$1.78

Market Cap

2.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EZRA
AEMD
Founded
2013
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Insurers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1M
2.1M
IPO Year
2020
2008

Fundamental Metrics

Financial Performance
Metric
EZRA
AEMD
Price
$2.80
$1.78
Analyst Decision
Hold
Analyst Count
0
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
123.8K
1.4M
Earning Date
05-14-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
85.79
N/A
EPS
N/A
N/A
Revenue
$12,430,959.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$0.51
52 Week High
$5.45
$5.89

Technical Indicators

Market Signals
Indicator
EZRA
AEMD
Relative Strength Index (RSI) 53.51 40.17
Support Level $2.10 $1.36
Resistance Level $3.24 $2.47
Average True Range (ATR) 0.27 0.27
MACD 0.02 -0.17
Stochastic Oscillator 53.27 5.56

Price Performance

Historical Comparison
EZRA
AEMD

About EZRA Reliance Global Group Inc. Common Stock

Reliance Global Group Inc operates as a holding company that acquires, owns, and actively manages insurance and technology-focused businesses. The company focuses on growing by pursuing acquisition strategies initially, and focuses on wholesale and retail insurance agencies. Its primary move is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations. The Company operates as a single operating segment, the Insurance Segment, earning its revenues from insurance commissions.

About AEMD Aethlon Medical Inc.

Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.

Share on Social Networks: